|
G |
Alas1 |
5'-aminolevulinate synthase 1 |
increases activity |
EXP |
pyridine results in increased activity of ALAS1 protein |
CTD |
PMID:10413312 |
|
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
|
|
G |
Cd86 |
CD86 molecule |
increases expression |
ISO |
pyridine results in increased expression of CD86 protein |
CTD |
PMID:19665512 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression increases activity |
ISO EXP |
CYP2E1 protein promotes the reaction [pyridine results in increased expression of CYP1A1 mRNA]; Dimethyl Sulfoxide inhibits the reaction [CYP2E1 protein promotes the reaction [pyridine results in increased expression of CYP1A1 mRNA]] pyridine results in increased expression of CYP1A1 mRNA; pyridine results in increased expression of CYP1A1 protein pyridine results in increased activity of CYP1A1 protein |
CTD |
PMID:1857340 PMID:2241968 PMID:7493548 PMID:7511897 PMID:10413312 PMID:10463385 PMID:11849738 PMID:12147272 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression increases activity |
EXP |
pyridine results in increased expression of CYP1A2 mRNA; pyridine results in increased expression of CYP1A2 protein pyridine results in increased activity of CYP1A2 protein |
CTD |
PMID:1857340 PMID:7493548 PMID:10413312 PMID:10463385 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
multiple interactions increases expression increases activity affects activity |
EXP |
INS protein affects the reaction [pyridine results in increased expression of CYP2B1 mRNA]; INS protein affects the reaction [pyridine results in increased expression of CYP2B1 protein]; pyridine promotes the reaction [ciprofibrate results in increased expression of CYP2B1 protein] pyridine results in increased expression of CYP2B1 mRNA; pyridine results in increased expression of CYP2B1 protein pyridine results in increased activity of CYP2B1 protein pyridine affects the activity of CYP2B1 protein |
CTD |
PMID:1610360 PMID:7587954 PMID:8246169 PMID:10215695 PMID:11181506 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
multiple interactions increases expression increases activity affects activity |
EXP |
pyridine promotes the reaction [ciprofibrate results in increased expression of CYP2B2 protein] pyridine results in increased expression of CYP2B2 mRNA; pyridine results in increased expression of CYP2B2 protein pyridine results in increased activity of CYP2B2 protein pyridine affects the activity of CYP2B2 protein |
CTD |
PMID:1610360 PMID:7587954 PMID:8246169 PMID:11181506 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions increases activity increases expression decreases activity |
ISO EXP |
CYP2E1 protein promotes the reaction [pyridine results in increased expression of CYP1A1 mRNA]; Dimethyl Sulfoxide inhibits the reaction [CYP2E1 protein promotes the reaction [pyridine results in increased expression of CYP1A1 mRNA]] pyridine results in increased activity of CYP2E1 protein pyridine results in increased expression of CYP2E1 mRNA; pyridine results in increased expression of CYP2E1 protein [pyridine co-treated with Methylcholanthrene] results in decreased expression of CYP2E1 mRNA; [pyridine co-treated with Methylcholanthrene] results in decreased expression of CYP2E1 protein; [pyridine co-treated with Methylcholanthrene] results in increased activity of CYP2E1 protein; [pyridine co-treated with Methylcholanthrene] results in increased expression of CYP2E1 protein; Cycloheximide inhibits the reaction [pyridine results in increased activity of CYP2E1 protein]; Cycloheximide inhibits the reaction [pyridine results in increased expression of CYP2E1 protein]; Ditiocarb inhibits the reaction [pyridine results in increased activity of CYP2E1 protein]; INS protein affects the reaction [pyridine results in increased expression of CYP2E1 protein]; pyridine promotes the reaction [ciprofibrate results in increased expression of CYP2E1 protein]; pyridine promotes the reaction [CYP2E1 protein results in increased hydroxylation of 4-nitrophenol] pyridine results in decreased activity of CYP2E1 protein |
CTD |
PMID:1379807 PMID:1610360 PMID:1968335 PMID:2241968 PMID:7587954 PMID:8074729 PMID:8246169 PMID:8734847 PMID:9618253 PMID:10215695 PMID:11181506 PMID:12147272 PMID:12464242 PMID:12919724 PMID:23211455 More...
|
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions increases expression increases activity |
EXP |
cordycepin inhibits the reaction [pyridine results in increased expression of CYP3A2 mRNA]; Cycloheximide inhibits the reaction [pyridine results in increased expression of CYP3A2 mRNA]; Dactinomycin inhibits the reaction [pyridine results in increased expression of CYP3A2 mRNA] pyridine results in increased expression of CYP3A2 mRNA; pyridine results in increased expression of CYP3A2 protein pyridine results in increased activity of CYP3A2 protein |
CTD |
PMID:11181506 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
multiple interactions increases expression increases activity |
EXP |
cordycepin inhibits the reaction [pyridine results in increased expression of CYP3A23-3A1 mRNA]; Cycloheximide inhibits the reaction [pyridine results in increased expression of CYP3A23-3A1 mRNA]; Dactinomycin inhibits the reaction [pyridine results in increased expression of CYP3A23-3A1 mRNA] pyridine results in increased expression of CYP3A23-3A1 mRNA; pyridine results in increased expression of CYP3A23-3A1 protein pyridine results in increased activity of CYP3A23-3A1 protein |
CTD |
PMID:11181506 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
pyridine promotes the reaction [Carbon Tetrachloride results in increased expression of FOS mRNA] |
CTD |
PMID:8825185 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
multiple interactions |
EXP |
pyridine analog binds to and results in decreased activity of GRIN2B protein |
CTD |
PMID:17768047 |
|
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases activity increases expression |
EXP |
pyridine results in increased activity of HMOX1 protein pyridine results in increased expression of HMOX1 mRNA; pyridine results in increased expression of HMOX1 protein |
CTD |
PMID:10413312 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
increases activity |
ISO |
pyridine results in increased activity of HSF1 protein |
CTD |
PMID:34170685 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
EXP |
INS protein affects the reaction [pyridine results in increased expression of CYP2B1 mRNA]; INS protein affects the reaction [pyridine results in increased expression of CYP2B1 protein]; INS protein affects the reaction [pyridine results in increased expression of CYP2E1 protein] |
CTD |
PMID:10215695 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
pyridine promotes the reaction [Carbon Tetrachloride results in increased expression of JUN mRNA] |
CTD |
PMID:8825185 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
affects binding |
ISO |
pyridine analog binds to KCNH2 protein |
CTD |
PMID:17768047 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
multiple interactions |
EXP |
Heme promotes the reaction [pyridine results in increased activity of TDO2 protein] |
CTD |
PMID:10413312 |
|
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
|
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
[Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which results in increased cleavage of CASP3 protein |
CTD |
PMID:17327230 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
[Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which results in increased cleavage of CASP9 protein |
CTD |
PMID:17327230 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO |
[Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which results in increased expression of CDKN1A protein |
CTD |
PMID:17327230 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
[Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which affects the localization of CYCS protein |
CTD |
PMID:17327230 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Hrh1 |
histamine receptor H 1 |
multiple interactions |
ISO EXP |
2-(2-aminoethyl)pyridine binds to and results in increased activity of HRH1 protein; HRH1 protein promotes the reaction [2-(2-aminoethyl)pyridine results in increased expression of IL6 mRNA] |
CTD |
PMID:9657254 PMID:16143415 |
|
NCBI chr 4:147,564,963...147,649,353
Ensembl chr 4:147,645,995...147,647,455
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
2-(2-aminoethyl)pyridine results in increased expression of IL6 mRNA HRH1 protein promotes the reaction [2-(2-aminoethyl)pyridine results in increased expression of IL6 mRNA] |
CTD |
PMID:9657254 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
SOD1 protein results in decreased susceptibility to [Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] |
CTD |
PMID:17327230 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
[Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which results in increased expression of TP53 protein |
CTD |
PMID:17327230 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
multiple interactions decreases activity |
ISO |
dipicolinic acid inhibits the reaction [[GLUD1 protein co-treated with Ketoglutaric Acids co-treated with NADP co-treated with Aminooxyacetic Acid] affects the reaction [Carbon Tetrachloride affects the abundance of Ammonia]] dipicolinic acid results in decreased activity of GLUD1 protein |
CTD |
PMID:26639393 |
|
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
ISO |
dipicolinic acid promotes the reaction [MAPT protein binds to MAPT protein] |
CTD |
PMID:31678113 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
|
G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
affects abundance |
EXP |
ACMSD protein affects the abundance of Quinolinic Acid |
CTD |
PMID:17896587 |
|
NCBI chr13:39,200,412...39,245,954
Ensembl chr13:39,200,314...39,245,209
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases activity |
ISO |
Quinolinic Acid results in increased activity of AHR protein |
CTD |
PMID:28336214 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP |
Quinolinic Acid results in increased expression of BAX mRNA [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in increased expression of BAX mRNA]; naringin inhibits the reaction [Quinolinic Acid results in increased expression of BAX mRNA]; Pioglitazone inhibits the reaction [Quinolinic Acid results in increased expression of BAX mRNA] |
CTD |
PMID:30130594 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
EXP |
Quinolinic Acid results in decreased expression of BCL2 mRNA [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of BCL2 mRNA]; naringin inhibits the reaction [Quinolinic Acid results in decreased expression of BCL2 mRNA]; Pioglitazone inhibits the reaction [Quinolinic Acid results in decreased expression of BCL2 mRNA] |
CTD |
PMID:30130594 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression |
EXP |
Quinolinic Acid results in increased expression of BDNF mRNA |
CTD |
PMID:15698628 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Casp3 |
caspase 3 |
increases expression increases activity multiple interactions |
EXP |
Quinolinic Acid results in increased expression of CASP3 mRNA Quinolinic Acid results in increased activity of CASP3 protein [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in increased expression of CASP3 mRNA]; Gallic Acid inhibits the reaction [Quinolinic Acid results in increased activity of CASP3 protein]; naringin inhibits the reaction [Quinolinic Acid results in increased expression of CASP3 mRNA]; Pioglitazone inhibits the reaction [Quinolinic Acid results in increased expression of CASP3 mRNA]; wedelolactone inhibits the reaction [Quinolinic Acid results in increased activity of CASP3 protein] |
CTD |
PMID:29981346 PMID:30130594 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
multiple interactions decreases activity decreases expression |
EXP |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [pioglitazone inhibits the reaction [Quinolinic Acid results in decreased activity of CAT protein]]; nimesulide inhibits the reaction [Quinolinic Acid results in decreased expression of CAT protein]; pioglitazone inhibits the reaction [Quinolinic Acid results in decreased activity of CAT protein]; rofecoxib inhibits the reaction [Quinolinic Acid results in decreased expression of CAT protein] |
CTD |
PMID:20043943 PMID:20450929 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Chat |
choline O-acetyltransferase |
multiple interactions decreases activity |
EXP |
Dizocilpine Maleate inhibits the reaction [Quinolinic Acid results in decreased activity of CHAT protein] |
CTD |
PMID:2976130 |
|
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
|
|
G |
Cp |
ceruloplasmin |
multiple interactions |
EXP |
[Copper Sulfate co-treated with Quinolinic Acid] results in increased activity of CP protein |
CTD |
PMID:12899943 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Dpp3 |
dipeptidylpeptidase 3 |
multiple interactions |
EXP |
Quinolinic Acid promotes the reaction [DPP3 protein binds to KEAP1 protein] |
CTD |
PMID:30876764 |
|
NCBI chr 1:202,204,683...202,228,501
Ensembl chr 1:202,204,693...202,228,541
|
|
G |
Drd1 |
dopamine receptor D1 |
decreases expression |
EXP |
Quinolinic Acid results in decreased expression of DRD1 protein |
CTD |
PMID:12207953 |
|
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
|
|
G |
Drd2 |
dopamine receptor D2 |
increases expression |
EXP |
Quinolinic Acid results in increased expression of DRD2 protein |
CTD |
PMID:12207953 |
|
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
multiple interactions |
EXP |
GW 506033X inhibits the reaction [Quinolinic Acid results in increased expression of and results in increased cleavage of EIF2AK2 protein]; Quinolinic Acid results in increased expression of and results in increased cleavage of EIF2AK2 protein |
CTD |
PMID:24211709 |
|
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases phosphorylation multiple interactions |
EXP |
Quinolinic Acid results in increased phosphorylation of EIF2S1 protein [Quinolinic Acid co-treated with GW 506033X] results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:24211709 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
decreases secretion |
ISO |
Quinolinic Acid results in decreased secretion of FGF1 protein |
CTD |
PMID:16392031 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
Quinolinic Acid results in increased expression of FOS mRNA |
CTD |
PMID:15698628 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases activity |
EXP |
Quinolinic Acid results in increased activity of G6PD protein |
CTD |
PMID:30876764 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Il1b |
interleukin 1 beta |
increases expression multiple interactions |
EXP |
Quinolinic Acid results in increased expression of IL1B mRNA; Quinolinic Acid results in increased expression of IL1B protein [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in increased expression of IL1B mRNA]; Gallic Acid inhibits the reaction [Quinolinic Acid results in increased expression of IL1B protein]; GW 506033X inhibits the reaction [Quinolinic Acid results in increased expression of IL1B protein]; naringin inhibits the reaction [Quinolinic Acid results in increased expression of IL1B mRNA]; Pioglitazone inhibits the reaction [Quinolinic Acid results in increased expression of IL1B mRNA]; wedelolactone inhibits the reaction [Quinolinic Acid results in increased expression of IL1B protein] |
CTD |
PMID:24211709 PMID:29981346 PMID:30130594 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
EXP |
[naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in increased expression of IL6 mRNA]; Gallic Acid inhibits the reaction [Quinolinic Acid results in increased expression of IL6 protein]; naringin inhibits the reaction [Quinolinic Acid results in increased expression of IL6 mRNA]; Pioglitazone inhibits the reaction [Quinolinic Acid results in increased expression of IL6 mRNA]; wedelolactone inhibits the reaction [Quinolinic Acid results in increased expression of IL6 protein] Quinolinic Acid results in increased expression of IL6 mRNA; Quinolinic Acid results in increased expression of IL6 protein |
CTD |
PMID:29981346 PMID:30130594 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions |
EXP |
Quinolinic Acid promotes the reaction [DPP3 protein binds to KEAP1 protein]; Quinolinic Acid promotes the reaction [SQSTM1 protein binds to KEAP1 protein]; Quinolinic Acid results in increased expression of and affects the localization of KEAP1 protein |
CTD |
PMID:30876764 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
ISO |
Quinolinic Acid promotes the reaction [MAPT protein binds to MAPT protein] |
CTD |
PMID:31678113 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
Quinolinic Acid results in increased activity of and affects the localization of NFE2L2 protein |
CTD |
PMID:30876764 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions decreases expression |
EXP |
[naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA]; naringin inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA]; Pioglitazone inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA] |
CTD |
PMID:30130594 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppif |
peptidylprolyl isomerase F |
increases response to substance |
ISO |
PPIF results in increased susceptibility to Quinolinic Acid |
CTD |
PMID:21378209 |
|
NCBI chr16:1,257,197...1,263,919
Ensembl chr16:1,257,106...1,263,913
|
|
G |
Rgs2 |
regulator of G-protein signaling 2 |
decreases expression |
EXP |
Quinolinic Acid results in decreased expression of RGS2 mRNA; Quinolinic Acid results in decreased expression of RGS2 protein |
CTD |
PMID:12207953 |
|
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
decreases expression increases expression |
EXP |
Quinolinic Acid results in decreased expression of SLC6A3 protein Quinolinic Acid results in increased expression of SLC6A3 protein |
CTD |
PMID:12207953 |
|
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases activity multiple interactions |
EXP |
Quinolinic Acid results in decreased activity of SOD1 protein Copper Sulfate inhibits the reaction [Quinolinic Acid results in decreased activity of SOD1 protein] |
CTD |
PMID:12899943 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
EXP |
Quinolinic Acid promotes the reaction [SQSTM1 protein binds to KEAP1 protein] |
CTD |
PMID:30876764 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
EXP |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Pioglitazone inhibits the reaction [Quinolinic Acid results in increased expression of TNF protein]]; [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in increased expression of TNF mRNA]; naringin inhibits the reaction [Quinolinic Acid results in increased expression of TNF mRNA]; Pioglitazone inhibits the reaction [Quinolinic Acid results in increased expression of TNF mRNA]; Pioglitazone inhibits the reaction [Quinolinic Acid results in increased expression of TNF protein] Quinolinic Acid results in increased expression of TNF mRNA; Quinolinic Acid results in increased expression of TNF protein |
CTD |
PMID:20450929 PMID:30130594 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|